CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Pancreatic Clampdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02987335
NCT02987335N/ACompleted

Metabolic Characteristics of Lean Diabetes in Rural and Semi-urban India and in the United States

Albert Einstein College of Medicine·observational·Posted Dec 8, 2016·Updated Dec 6, 2022

In Brief

An observational study evaluating Pancreatic Clamp for Malnutrition; Diabetes and Diabetes. Completed, enrolled 100 participants.

Detailed Summary

This purpose of this study is to define the metabolic characteristics of individuals with Lean Diabetes. We aim to determine whether differences in body composition, including any differences in lipid (fat) deposition, exist compared to individuals with either known forms of diabetes (eg, type 1 and type 2), or individuals without diabetes. Diabetes affects the ability of the body to process glucose (sugar). Therefore, we also plan to investigate the ability of the hormone insulin to regulate changes in glucose in these individuals. Developing a greater understanding of the features of this condition could have tremendous therapeutic benefit for these individuals.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
Countries--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedDec 8, 2016
Enrollment StartDec 1, 2010
Primary CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 7 yearsPosted 9.6 years ago

Interventions

Pancreatic Clampdrug

We are not performing any interventions; we are only characterizing participants using tests. The hormones that we are administering are not a treatment but are typically used in context of routine care.